{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:24Z","timestamp":1786118844623,"version":"build-2736575974"},"reference-count":36,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2569749","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:33:38Z","timestamp":1760535218000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Summary of final data from the 9-valent human papillomavirus vaccine pregnancy registry (2014\u20132021)"],"prefix":"10.1080","volume":"21","author":[{"given":"Cathy","family":"Hardalo","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Marko","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Sciba","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rausch","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Sieger","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Leong","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Tota","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Luxembourg","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_3_4_2_1","volume-title":"Summary of product characteristics","author":"Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)","year":"2024","unstructured":"Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). Summary of product characteristics. Merck Sharp & Dohme B.V.; 2024."},{"key":"e_1_3_4_3_1","volume-title":"Prescribing information","author":"Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)","year":"2025","unstructured":"Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant). Prescribing information. Merck Sharp & Dohme; 2025."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1383158"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky045"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/597071"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.03.030"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.071"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20259"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20174"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4340"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4387"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c2ca21"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612296"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1403702"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.014"},{"key":"e_1_3_4_17_1","unstructured":"US Food and Drug Administration. Approval letter - Gardasil 9. 2014. https:\/\/wayback.archive-it.org\/7993\/20190425005410\/https:\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm426520.htm."},{"key":"e_1_3_4_18_1","unstructured":"Centers for Disease Control and Prevention (CDC). Birth Defects and Genetic Diseases Branch 6-digit code for reportable congenital anomalies. n.d. [accessed 2024 May 20]. https:\/\/www.cdc.gov\/birth-defects\/tracking\/."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20350"},{"key":"e_1_3_4_20_1","unstructured":"March of Dimes. Low birthweight. 2021. https:\/\/www.marchofdimes.org\/find-support\/topics\/birth\/low-birthweight."},{"key":"e_1_3_4_21_1","unstructured":"March of Dimes. Preterm babies. 2024. https:\/\/www.marchofdimes.org\/find-support\/topics\/birth\/preterm-babies."},{"issue":"1","key":"e_1_3_4_22_1","first-page":"1","article-title":"Update on overall prevalence of major birth defects\u2013Atlanta, Georgia, 1978-2005","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects\u2013Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008;57(1):1\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_23_1","volume-title":"Danforth\u2019s obstetrics and gynecology","author":"Branch W","year":"2003","unstructured":"Branch W, Scott JR. Early pregnancy loss. In: Scott JR, Gibbs RS, Karlan BY, Haney AF, editors. Danforth\u2019s obstetrics and gynecology. 9th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2003. p. 75\u201390.","edition":"9"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002899"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.03.009"},{"key":"e_1_3_4_26_1","volume-title":"Brenner & Rector\u2019s the kidney","author":"Rosenblum ND","year":"2016","unstructured":"Rosenblum ND. Malformation of the kidney: structural and functional consequences. In: Skorecki K, Chertow G, Marsden PM, Taal MW, Yu ASL, editors. Brenner & Rector\u2019s the kidney. 10th ed. Philadelphia (PA): Elsevier; 2016. p. 2294\u20132307.","edition":"10"},{"key":"e_1_3_4_27_1","unstructured":"Baskin LS. Fetal hydronephrosis: etiology and prenatal management. 2023. https:\/\/www.uptodate.com\/contents\/fetal-hydronephrosis-etiology-and-prenatal-management."},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389202916666151014222815"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000519911"},{"key":"e_1_3_4_30_1","first-page":"1","article-title":"Diagnosis and treatment of fetal tachyarrhythmias","volume":"3","author":"Avari JN","year":"2006","unstructured":"Avari JN, Rhee EK. Diagnosis and treatment of fetal tachyarrhythmias. US Cardiol Rev. 2006;3:1\u20135.","journal-title":"US Cardiol Rev"},{"key":"e_1_3_4_31_1","unstructured":"Dubin AM. Clinical features and diagnosis of supraventricular tachycardia (SVT) in children. 2023. https:\/\/www.uptodate.com\/contents\/clinical-features-and-diagnosis-of-supraventricular-tachycardia-svt-in-children."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.153.3.267"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00823.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1058-9813(00)00033-3"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.18332\/ejm\/161793"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1181919"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a3"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2569749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2569749","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2569749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:43:32Z","timestamp":1786034612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2569749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2569749"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2569749","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2569749"}}